Search
for
Sort by
Research 151–180 of 1000+
- Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia
- Quality of Life Assessment in Male Patients with Androgenetic Alopecia: Result of a Prospective, Multicenter Study
- Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata
- Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata
- ANALYSIS OF THE RELATION BETWEEN ALOPECIA AND RESISTANCE TO 1,25‐DIHYDROXYVITAMIN D
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- A Comparison of the Efficacy, Relapse Rate and Side Effects among Three Modalities of Systemic Corticosteroid Therapy for Alopecia Areata
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Trichoscopy in alopecias: Diagnosis simplified
- Treatment of alopecia areata: An Australian expert consensus statement
- Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review
- Onion Juice (Allium cepa L.), A New Topical Treatment for Alopecia Areata
- Alopecia Areata: An Updated Review for 2023
- Cytokines and growth factors influence hair growth in vitro. Possible implications for the pathogenesis and treatment of alopecia areata
- Histopathologic Evaluation of Alopecias
- Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- Trichoscopy of alopecia areata: An update
- THE PATHOGENESIS OF ALOPECIA AREATA
- Rickets and Alopecia with Resistance to 1,25-Dihydroxyvitamin D: Two Different Clinical Courses with Two Different Cellular Defects*
- Alopecia: possible causes and treatments, particularly in captive nonhuman primates.
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia
- Role of the Autoimmune Regulator (<i>AIRE</i>) gene in alopecia areata: Strong association of a potentially functional <i>AIRE</i> polymorphism with alopecia universalis
- Alopecia Areata Update
- 308-nm excimer laser therapy in alopecia areata
- Alopecia areata in children:, response to treatment with diphencyprone